Indogulf Cropsciences Ltd
Incorporated in 1993, Indogulf Cropsciences Limited is engaged in manufacturing crop protection products, plant nutrients, and biologicals in India.[1]
- Market Cap ₹ 413 Cr.
- Current Price ₹ 65.3
- High / Low ₹ 122 / 49.5
- Stock P/E 11.5
- Book Value ₹ 69.4
- Dividend Yield 0.00 %
- ROCE 13.2 %
- ROE 12.2 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.94 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 3.78% over past five years.
- Company has a low return on equity of 12.8% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals
Part of BSE IPO
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|
| 492 | 443 | 486 | 551 | 553 | 592 | 663 | |
| 457 | 404 | 442 | 501 | 493 | 528 | 593 | |
| Operating Profit | 35 | 39 | 45 | 49 | 60 | 64 | 70 |
| OPM % | 7% | 9% | 9% | 9% | 11% | 11% | 11% |
| 3 | 2 | 4 | 1 | -2 | 6 | 9 | |
| Interest | 5 | 5 | 6 | 11 | 12 | 14 | 16 |
| Depreciation | 5 | 6 | 8 | 8 | 9 | 10 | 11 |
| Profit before tax | 28 | 31 | 36 | 31 | 36 | 45 | 52 |
| Tax % | 28% | 26% | 26% | 26% | 21% | 29% | |
| 20 | 23 | 26 | 23 | 29 | 32 | 36 | |
| EPS in Rs | 52.30 | 9.77 | 11.26 | 9.80 | 12.19 | 6.58 | 6.32 |
| Dividend Payout % | 10% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 4% |
| 3 Years: | 7% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 9% |
| 3 Years: | 6% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 14% |
| 3 Years: | 13% |
| Last Year: | 12% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 24 | 24 | 24 | 24 | 49 | 63 |
| Reserves | 127 | 131 | 157 | 180 | 209 | 228 | 376 |
| 92 | 79 | 102 | 189 | 155 | 222 | 204 | |
| 150 | 178 | 139 | 121 | 154 | 183 | 214 | |
| Total Liabilities | 373 | 411 | 421 | 513 | 541 | 682 | 856 |
| 47 | 51 | 53 | 65 | 44 | 47 | 47 | |
| CWIP | 4 | 6 | 9 | 9 | 22 | 57 | 67 |
| Investments | 3 | 3 | 0 | 0 | 0 | 0 | 15 |
| 319 | 352 | 359 | 440 | 474 | 578 | 727 | |
| Total Assets | 373 | 411 | 421 | 513 | 541 | 682 | 856 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| -17 | 20 | -9 | 31 | 36 | -12 | |
| -35 | -10 | -10 | 0 | 0 | -40 | |
| 52 | -9 | 20 | 0 | 0 | 58 | |
| Net Cash Flow | 0 | 1 | 0 | 31 | 36 | 6 |
| Free Cash Flow | -52 | 10 | -21 | 31 | 36 | -52 |
| CFO/OP | -25% | 71% | 1% | 63% | 61% | 0% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 88 | 97 | 115 | 117 | 146 | 140 |
| Inventory Days | 154 | 205 | 167 | 201 | 195 | 229 |
| Days Payable | 96 | 138 | 111 | 79 | 109 | 116 |
| Cash Conversion Cycle | 147 | 164 | 171 | 239 | 231 | 253 |
| Working Capital Days | 51 | 62 | 86 | 94 | 114 | 114 |
| ROCE % | 16% | 16% | 12% | 13% | 13% |
Insights
In beta| Apr 2019 | Feb 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Formulation Capacity (Solid/Powder/Granules) MTPA |
|
|||||
| Technical Grade Capacity TPA / MTPA |
||||||
| Formulation Capacity (Liquid) KLPA |
||||||
| Number of B2C Distributors Number |
||||||
| Overall Capacity Utilization % |
||||||
| Product Registrations (CIB/Export) Number |
||||||
| Revenue contribution from New Product Launches (past 3 years) % |
||||||
| Working Capital Cycle Days |
||||||
| Number of Products/SKUs Number |
||||||
Documents
Announcements
-
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
31 Mar - Postal ballot (27 Feb–28 Mar 2026): reappointments of Om P. Aggarwal, Sanjay Aggarwal, Rahul Gupta, Sandeep Bhutani approved.
- Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot 31 Mar
- Closure of Trading Window 25 Mar
-
Appointment Of Investor Relation Agency
23 Mar - Indogulf appoints M/s Adfactors PR as investor relations agency effective April 1, 2026; contact investors@groupindogulf.com.
-
Announcement under Regulation 30 (LODR)-Change in Management
20 Mar - Secretarial Auditor Deepak Rawat resigned March 17, 2026 due to health reasons; no other material reasons.
Annual reports
Concalls
-
Feb 2026Transcript PPT
-
Nov 2025Transcript PPT
-
Aug 2025Transcript PPT
Business Profile[1]
Indogulf Cropsciences Limited is an agrochemical company engaged in the manufacturing and marketing of crop protection products, plant nutrients, and biologicals. It operates across India and exports to over 34 countries. It serves both retail (B2C) and institutional (B2B) customers and also offers contract manufacturing services.